-
Sector Analysis
NewAsia-Pacific (APAC) Food Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Asia-Pacific (APAC) Food Market Overview The Asia-Pacific (APAC)  food market was valued at $1,379.1 billion in 2023. The market will grow at a CAGR of more than 5% during 2023-2028. Sales of food products with health & wellness (H&W) attributes have grown significantly in Asia-Pacific due to consumers’ increasing concerns about heart disease, obesity, and high cholesterol. APAC Food Market Outlook 2023-2028 ($ Billion) Buy the Full Report for more Insights on the APAC Food Market Forecast, Download a Free...
-
Product Insights
NewLikelihood of Approval Analysis for Liposarcoma
Overview How likely is it that the drugs in Liposarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liposarcoma Overview Liposarcoma is a rare tumor derived from fat tissue that occurs...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperlipidemia
Overview How likely is it that the drugs in Hyperlipidemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperlipidemia Overview Hyperlipidemia is a medical condition characterized by elevated levels of lipids...
-
Sector Analysis
NewEastern Europe Food Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Eastern Europe Food Market Overview The Eastern Europe food market was valued at $219.9 billion in 2023. The market will grow at a CAGR of more than 4% during 2023-2028. The region will register the fastest volume CAGR and the second-fastest value CAGR during 2023–28. Economies will recover from the adverse impact of the escalation of the Russia–Ukraine conflict and high inflation. Improved consumer confidence will help the food industry grow. Eastern Europe Food Market Outlook 2023-2028 ($ Billion) Buy...
-
Product Insights
NewLikelihood of Approval Analysis for Cardiovascular Inflammation
Overview How likely is it that the drugs in Cardiovascular Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiovascular Inflammation Overview Cardiovascular inflammation refers to inflammation that occurs in the...
-
Sector Analysis
NewMiddle East and Africa (MEA) Food Market Opportunities, Trends, Growth Analysis and Forecast to 2028
This report brings together multiple data sources to provide a comprehensive overview of the Middle East and Africa food industry, analyzing data from 23 countries in the region. It includes an analysis of the following: Market Environment: Includes industry size, market size, and growth analysis by the top five sectors: meat, dairy & soy food, bakery & cereals, savory & deli foods, and oils & fats. High-Potential Countries’ Analysis: Indicates changing share of value consumption of various food products by...
-
Product Insights
NewLikelihood of Approval Analysis for Lipid Disorders
Overview How likely is it that the drugs in Lipid Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Disorders Overview Abnormal levels of triglycerides and LDL in the blood....
-
Product Insights
NewLikelihood of Approval Analysis for Obesity
Overview How likely is it that the drugs in Obesity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obesity Overview Obesity, a complex medical condition characterized by excessive body fat accumulation,...
-
Product Insights
NewLikelihood of Approval Analysis for Non-Rhabdomyosarcoma
Overview How likely is it that the drugs in Non-Rhabdomyosarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Rhabdomyosarcoma Overview Non-rhabdomyosarcoma refers to a group of cancers that are distinct from...